PMID: 42335260
Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.
Spitery Allison, Lobkovich Alison, Thomas Emily
The American journal of managed care · 2026
Vol. 32, Issue 6, pp. 328-333
This entry links to third-party literature. For research use only.
HumansGlucagon-Like PeptidesSemaglutideRecombinant Fusion ProteinsDiabetes Mellitus, Type 2Immunoglobulin Fc FragmentsFemaleWeight LossRetrospective StudiesMale